Zhejiang: 9 over consistency evaluation drugs are adjusted to the lowest price in China!

Medical network, Nov 26 recently, Zhejiang Pharmaceutical machinery purchasing center announced that 9 drugs with consistency evaluation were adjusted to the lowest price in China ▍ the lowest price in China According to the announcement, according to the spirit of the notice on the direct online procurement of generic drugs through the consistency evaluation of quality and efficacy (zyjf [2018] No 6) issued by the provincial drug centralized procurement leading group office, the procurement transaction price of generic drugs through the consistency evaluation in our province shall not be higher than the online procurement price and the winning price of other provinces after the consistency evaluation Some enterprises have newly submitted the price of products in other provinces after the conformity evaluation, and now they adjust the price information of relevant products, and the price adjustment will be implemented from now on In addition to Zhejiang Province, there are many other provinces that have asked for the lowest price of drugs for conformity assessment ▍ 4 provinces all require low price linkage of evaluated drugs [Shanxi] On March 16, 2018, the health and Family Planning Commission of Shanxi Province issued a notice requiring that the drug varieties approved by the State Food and Drug Administration for conformity assessment of quality and efficacy of generic drugs and the drugs conforming to the relevant provisions shall be deemed to have passed the conformity assessment, which can be included in the scope of centralized purchase of drugs in Shanxi Province, and the price shall be negotiated by medical institutions and drug production (distribution) enterprises themselves Purchase The enterprise shall promise that the price of the product sold in Shanxi shall not be higher than that in other provinces [Guangxi] on May 11, 2018, Guangxi Province issued a notice, requiring that the drugs that have passed the consistency evaluation and meet the relevant national regulations shall be deemed as those that have passed the consistency evaluation to be directly purchased online The average value of the lowest five provincial shortlisted prices provided and promised by the enterprise shall be taken as the reference price for online purchase, and the purchase price shall be negotiated by the medical institutions before purchase [Jiangsu] on April 9, 2018, Jiangsu public resources trading center issued the notice on submitting innovative drugs and materials related to generic drugs through consistency evaluation The core content of this notice is to require the manufacturers of innovative drugs and generic drugs that have passed the consistency evaluation to independently declare the drug supply price, and promise that this price is the lowest price in the country [Shaanxi] on March 6, 2018, Shaanxi issued a notice that the drugs passing the consistency evaluation will be treated equally with the original research drugs when they are purchased centrally in Shaanxi Province For the evaluation varieties that are not centralized purchasing results of essential drugs and public hospital drugs in Shaanxi Province, it is allowed to directly hang the network, with the lowest average price of three provinces in China and the low price of the current hanging network price in Shaanxi Province as the price limit As we all know, except for the drugs with consistency evaluation, almost all the drugs on the Internet face the linkage of the lowest price The lowest price linkage, without considering the huge difference in the actual dosage of drugs in each province, requires a single price linkage, and the power of price reduction is not small In fact, there is an obvious contradiction between the requirement of "price only" in the linkage of the lowest price and the requirement of "quantity" in the volume purchase And the new National Health Insurance Bureau led by the volume of procurement, it is particularly clear "volume" this essential element ▍ according to the procurement documents, the pilot areas are 11 cities including Beijing, Tianjin, Shanghai, Chongqing and Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu and Xi'an The first batch of 31 varieties are included in the purchase catalogue, including cefuroxime ester tablets, escitalopram oxalate tablets, rosuvastatin calcium tablets, etc which have passed the consistency evaluation of 3 enterprises There has been speculation in the industry before that the specific implementation of "4+7 procurement with quantity" will be entrusted to Shanghai pharmaceutical centralized bidding and procurement agency According to the documents issued by Shanghai Pharmaceutical centralized bidding and Purchasing Management Institute for many times, the linking of quantity and price is undoubtedly the biggest bright spot ▍ the quantity price linkage will continue to impact the linkage of the lowest price As early as before the national procurement plan with volume was published, the procurement quantity was defined in the bidding documents of Shanghai According to the Shanghai bidding and procurement documents, in principle, the procurement volume of the bid winning enterprise in this centralized bidding shall not be lower than the sales volume of the bid winning varieties of the enterprise in 2016 in the whole city (based on the sunshine platform data), and the specific procurement volume shall be executed according to the signed tripartite agreement Production enterprises bid according to the expected trading volume and realize the volume price linkage Take the third batch of purchased varieties with volume in Shanghai as an example, the bidding quantity of each specification of each variety is announced specifically In addition, in order to ensure the effective implementation of the procurement volume, Shanghai has also set up a procurement postponement mechanism to ensure the actual use of procurement varieties On November 21, the Shanghai Municipal Administration of pharmaceutical centralized bidding and purchase Affairs issued the supplementary document of 4 + 7 urban pharmaceutical centralized purchase in Shanghai (hereinafter referred to as the "document"), again emphasizing the "linking of quantity and price" Previously, the relevant people of the medical insurance bureau said in public that from the perspective of the pilot cities selected by the medical insurance bureau, the National Medical Insurance Bureau attaches great importance to the pilot work of the volume procurement With the gradual promotion of the procurement with volume led by the state health insurance bureau, the logic of linking volume and price has been generally recognized As for the linkage of the lowest price with a single emphasis on low price, its survival foundation may be loose